• HC Wainwright Reiterates Buy Rating for Halozyme Therapeutics (NASDAQ:HALO)

    Source: Buzz FX / 04 Feb 2025 08:32:09   America/New_York


    HC Wainwright Reiterates Buy Rating for Halozyme Therapeutics (NASDAQ:HALO) Written by MarketBeat February 4, 2025 Share Link copied to clipboard. Halozyme Therapeutics ( NASDAQ:HALO - Get Free Report ) 's stock had its "buy" rating reaffir
    Read more...
Share on,